Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
5,359,889
-
Shares change
-
-58,959
-
Total reported value, excl. options
-
$7,289,360
-
Value change
-
-$137,360
-
Put/Call ratio
-
31%
-
Number of buys
-
10
-
Number of sells
-
7
-
Price
-
$1.36
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2022
As of 30 Sep 2022 VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,359,889 shares of stock of the company.
Largest 10 holders included Lagoda Investment Management, L.P., VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Bank Julius Baer & Co. Ltd, Zurich, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Cowen Prime Advisors LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 38 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.